SEC Form 3/A · accession 0001104659-18-063102
Osmotica Pharmaceuticals plc · OSMT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 3/A). It replaces an earlier filing for the same period.
Reporting owner
David F Burgstahler
Director · 10% Owner
Period of report
Oct 18, 2018
Accepted (ET)
Oct 19, 2018 · 7:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001739426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | holding | — | — | — | 9,296,965 | I | By Avista Capital investment fund | |
| Ordinary SharesF1,F3 | holding | — | — | — | 5,183,899 | I | By Avista Capital investment fund | |
| Ordinary SharesF4 | holding | — | — | — | 4,936,926 | I | By Avista Capital investment fund | |
| Ordinary SharesF5 | holding | — | — | — | 1,032,995 | I | By Avista Capital investment fund |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This amendment to the reporting person's Form 3 filed on October 18, 2018 is being filed to correct the number of ordinary shares reported as beneficially owned in the original Form 3.
- F2Represents shares of the Issuer held by ACP III AIV, L.P. Avista Capital Partners III GP, L.P. ("ACP GP") is the general partner of ACP III AIV, L.P. Mr. Burgstahler is a member of the investment committee of ACP GP. By virtue of this relationship, Mr. Burgstahler may be deemed to share voting and investment power with respect to the shares held by ACP III AIV, L.P. Mr. Burgstahler disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
- F3Represents shares of the Issuer held by ACP Holdco (Offshore), L.P. ACP GP is the general partner of ACP Holdco (Offshore), L.P. Mr. Burgstahler is a member of the investment committee of ACP GP. By virtue of this relationship, Mr. Burgstahler may be deemed to share voting and investment power with respect to the shares held by ACP Holdco (Offshore). Mr. Burgstahler disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
- F4Represents shares of the Issuer held by Orbit Co-Invest I LLC. ACP GP is the manager of Orbit Co-Invest I LLC. Mr. Burgstahler is a member of the investment committee of ACP GP. By virtue of this relationship, Mr. Burgstahler may be deemed to share voting and investment power with respect to the shares held by Orbit Co-Invest I LLC. Mr. Burgstahler disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
- F5Represents shares of the Issuer held by Orbit Co-Invest III LLC. ACP GP is the manager of Orbit Co-Invest III LLC. Mr. Burgstahler is a member of the investment committee of ACP GP. By virtue of this relationship, Mr. Burgstahler may be deemed to share voting and investment power with respect to the shares held by Orbit Co-Invest III LLC. Mr. Burgstahler disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.